Departamento de Biofísica e Farmacologia, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.
Departamento de Microbiologia e Parasitologia, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.
J Biomol Struct Dyn. 2023 May;41(8):3321-3338. doi: 10.1080/07391102.2022.2050301. Epub 2022 Mar 14.
Mayaro virus (MAYV) is an arbovirus found in the Americas that can cause debilitating arthritogenic disease. Although it is an emerging virus, the only current approach is vector control, as there are no approved vaccines to prevent MAYV infection nor therapeutics to treat it. In search of an effective vaccine candidate against MAYV, we used immunoinformatics and molecular modeling to attempt to identify promiscuous T-cell epitopes of the nonstructural polyproteins (nsP1, nsP2, nsP3, and nsP4) from 127 MAYV genomes sequenced in the Americas (08 Bolivia, 72 Brazil, 04 French Guiana, 05 Haiti, 20 Peru, 04 Trinidad and Tobago, and 14 Venezuela). For this purpose, consensus sequences of 360 proteins were used to identify short protein sequences that can bind to MHC I class (MHC II). Our analysis revealed 56 potential MHC-I/TCD8+ (29 MHC-II/TCD4+) epitopes, but only 6 (16) TCD8+ (TCD4+) epitopes showed high antigenicity and conservation, non-allergenicity, non-toxicity, and excellent population coverage. Finally, classical and quantum mechanical calculations (QM:MM) were used to improve the quality of the docking calculations, with the QM part of the simulations performed using the density functional theory formalism (DFT). These results provide insights for the advancement of diagnostic platforms, vaccine development, and immunotherapeutic interventions.Communicated by Ramaswamy H. Sarma.
马亚罗病毒(MAYV)是一种在美洲发现的虫媒病毒,可引起使人虚弱的关节炎疾病。尽管它是一种新兴病毒,但目前唯一的方法是控制病媒,因为没有经过批准的疫苗可预防 MAYV 感染,也没有治疗方法。为了寻找针对 MAYV 的有效疫苗候选物,我们使用免疫信息学和分子建模来尝试识别美洲 127 个 MAYV 基因组中非结构多蛋白(nsP1、nsP2、nsP3 和 nsP4)的混杂 T 细胞表位(08 年玻利维亚、72 年巴西、04 年法属圭亚那、05 年海地、20 年秘鲁、04 年特立尼达和多巴哥和 14 年委内瑞拉)。为此,使用 360 个蛋白质的共识序列来识别可以与 MHC I 类(MHC II)结合的短蛋白质序列。我们的分析揭示了 56 个潜在的 MHC-I/TCD8+(29 个 MHC-II/TCD4+)表位,但只有 6 个(16 个)TCD8+(TCD4+)表位显示出高抗原性和保守性、非变应原性、非毒性和优异的人群覆盖率。最后,使用经典和量子力学计算(QM:MM)来提高对接计算的质量,使用密度泛函理论形式(DFT)进行模拟的 QM 部分。这些结果为推进诊断平台、疫苗开发和免疫治疗干预提供了思路。由 Ramaswamy H. Sarma 传达。